100 results
Page 4 of 5
8-K
d19tc03louof6gua
15 Mar 21
VBI Vaccines to Present at Oppenheimer 31st Annual Healthcare Conference
8:00am
8-K
EX-99.1
5vkwi
15 Mar 21
VBI Vaccines to Present at Oppenheimer 31st Annual Healthcare Conference
8:00am
8-K
EX-99.1
tl9ma8y25ubh5tpyg7p
15 Jan 21
VBI Vaccines Announces Publication of Results from a Phase 4 Study of VBI’s
8:24am
8-K
EX-99.1
z7vy3oa13
7 Dec 20
VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine
10:23am
8-K
EX-99.1
x5662 acm0z
1 Dec 20
VBI Vaccines Announces Submission of Biologics License Application to FDA for 3-Antigen Prophylactic Hepatitis B Vaccine
8:16am
8-K
EX-99.1
phpmuf0cw96i8go
3 Aug 20
VBI Vaccines Announces Second Quarter 2020 Financial Results and Provides Corporate Update
9:10am
S-3ASR
EX-1.2
cr05a8w
31 Jul 20
Automatic shelf registration
4:58pm
8-K
EX-99.1
7xqnn8wf
17 Jun 20
VBI Vaccines to Present at Upcoming Investor Conferences
8:54am
8-K
EX-99.1
c4wc8etgek
27 May 20
VBI Vaccines Secures $50 Million Debt Financing From K2 HealthVentures
5:15pm
8-K
EX-1.1
qbxso 61fn8px2l
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
8-K
EX-99.1
rfs7duc
13 Mar 20
VBI Vaccines Appoints Damian Braga to Board of Directors
12:59pm
424B5
74lg3relmo6gdjw
20 Sep 19
Prospectus supplement for primary offering
5:28pm
8-K
EX-1.1
5hfsm jtlu7w0
20 Sep 19
VBI Vaccines Announces Proposed Public Offering of Common Shares
5:27pm